Less Ads, More Data, More Tools Register for FREE

Financial Results March 2025

12 May 2025 09:19

RNS Number : 2512I
UPL Limited
12 May 2025
 

UPL LIMITED

 

Sub: 

1. Audited Consolidated and standalone Financial Results for the quarter and financial year ended 31st March 2025 and recommendation of dividend.

2. Press Release.

3. Investor Presentation.

 

Dear Sir/Madam,

 

The Board of Directors of the Company ("Board") held today i.e. Monday, 12th May 2025, has considered and approved the audited consolidated and standalone financial results of the Company for the quarter and financial year ended 31st March 2025.

The Board has recommended a dividend of 300% i.e. Rs. 6/- per equity share on equity shares ofRs. 2/-each (on fully paid-up equity shares and partly paid-up equity shares in proportion to their share in the paid-up equity share capital), subject to approval of members at the ensuing Annual General Meeting (AGM).

The links for Financial results, Press Release and Investor Presentation are mentioned below:-

 

Links:

 

1. Financials: -

 

https://www.bseindia.com/xml-data/corpfiling/AttachLive/059f1d7e-e476-4eeb-868a-cbb7e472b58c.pdf

 

2. Press Release:-

 

https://www.bseindia.com/xml-data/corpfiling/AttachLive/a7aceb99-1176-41bb-8afc-1b626e6fb83c.pdf

 

3. Investor Presentation:-

 

https://www.bseindia.com/xml-data/corpfiling/AttachLive/38a2270a-8a9a-4206-8333-bc732990299c.pdf

 

 

We request you to take note of the same.

 

Thanking you,

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CIREAPSAFFLSEEA

Related Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Back to RNS